Trial Profile
A study investigating the effect of voriconazole, caspofungin or combination of voriconazole and caspofungin in hematological malignancies patients with invasive aspergillosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Caspofungin (Primary) ; Voriconazole (Primary)
- Indications Aspergillosis; Invasive bronchopulmonary aspergillosis
- Focus Therapeutic Use
- 25 Nov 2015 New trial record